StreetAlpha.app
Home › Stocks › AFYA

Afya Ltd (AFYA)

Consumer Defensive
$10.30
▲ +2.08%
LAST CLOSE · NOV 17

Afya provides medical education and clinical tools for physicians, based in Belo Horizonte, Brazil. It last closed at $10.30 on Nov 17, up 2.08% on the day. The average 12-month price target from 2 analysts is $14.75 (+43.2% from the last close), with a high of $17.50 and a low of $12.00. In the past 30 days there were 1 dark pool print totaling $1.1M, the largest $1.1M.

AI Auto Pilots
Is AFYA in one of our four AI portfolios? Sign in free to see

Key Stats

Fiscal 2025
Results
Revenue
BRL 3.7B
+11.9% vs a year ago
Net income
BRL 752.5M
+19.2% vs a year ago
Free cash flow
BRL 1.4B
36.9% margin
Gross margin
64.5%
BRL 2.4B gross profit
Balance sheet
Cash & equivalents
BRL 1.1B
At Dec 31
Shareholder equity
BRL 4.9B
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: BRL 1.7BBRL 1.7BFY2021FY2022: BRL 2.3BBRL 2.3BFY2022FY2023: BRL 2.9BBRL 2.9BFY2023FY2024: BRL 3.3BBRL 3.3BFY2024FY2025: BRL 3.7BBRL 3.7BFY2025

From AFYA's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 31). Figures are in BRL. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated AFYA in the past 90 days, not enough for a consensus
Average 12-month target
$14.75
▲ 43.2% upside

Based on 2 analysts who set a price target on AFYA in the past 90 days. The average target is $14.75, with a high of $17.50 and a low of $12.00, compared with the last close of $10.30.

Low $12.00Avg $14.75High $17.50
Blue marker: last close $10.30
Highest target$17.50
Average target$14.75
Lowest target$12.00
Latest rating changes
JP MorganTarget lowered
Nov 3Buy$19 → $17.50
CitigroupUpgrade
Nov 3Buy$12
JP MorganUpgrade
Oct 7Buy$21 → $19
JP MorganMaintained
Jun 22Hold$21
DateFirmActionRatingPrice target
Nov 3JP MorganTarget loweredBuy$19 → $17.50
Nov 3CitigroupUpgradeBuy$12
Oct 7JP MorganUpgradeBuy$21 → $19
Jun 22JP MorganMaintainedHold$21
Loading…

Technical Analysis

AFYA · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold

The stock is 8% below its 20 day and 23% below its 50 day average. It is 35% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 35), near oversold. The nearest support is the Pivot at $10.26, and the nearest resistance the Pivot R1 at $10.39.

Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 5.7%/day
Key levels
$16.1652 week high+56.9%
$13.94200 day average+35.3%
$13.44100 day average+30.5%
$12.6550 day average+22.8%
$11.1320 day average+8.1%
$10.96Swing high (Nov 11)+6.4%
$10.39Pivot R1+0.9%
$10.30Last close
$10.26Pivot−0.4%
$10.17Pivot S1−1.3%
$9.97Swing low (Nov 5)−3.2%
$9.6652 week low−6.2%
Indicators
RSI (14)35.33Weak, oversold below 30Neutral
MACD-0.81Above its signal lineBullish
Stochastic41.3Middle of its rangeNeutral
ADX (14)40.3Strong downtrend
Williams %R-53.3Oversold below −80, overbought above −20Neutral
CCI (20)-53.2Oversold below −100, overbought above 100Neutral
Rate of change−2.4%Change over 10 sessionsBearish
ATR (14)$0.58Typical daily range, 5.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for AFYA

What happened before

See how AFYA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow AFYA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How AFYA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in AFYA in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
1
Notional
$1.1M
Largest print
$1.1M
Loading…

AFYA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲37 buying vs 29 selling
  • ▲Shares held by funds +12.3%
  • ▲Funds holding +6
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding6155+10.9%
In funds' top 10110.0%
Held by funds–––
New / increased17 / 2010 / 12+68.2%
Reduced / sold out17 / 1219 / 9+3.6%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See AFYA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AFYA is in one of them and how their past AFYA trades turned out.

AFYA in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered AFYA in an article yet. Here's the latest on the wider market.

About Afya

Afya is an education and healthcare services company based in Belo Horizonte, Minas Gerais, Brazil. Its Undergraduate segment offers medical school and other health science degrees, and tuition fees are its main source of revenue. Its Continuing Education segment provides medical training, including residency and specialization test preparation, plus graduate courses in medicine delivered online and in person. Its Medical Practice Solutions segment offers clinical decision and management tools for physicians and helps healthcare providers manage demand and efficiency.

Headquarters
Belo Horizonte, Minas Gerais